tiprankstipranks
Advertisement
Advertisement

ARTV Stock Latest News

Artiva: Sufficient Cash Runway to 2027 Supports Buy Rating Ahead of Key 2026 RA Efficacy Readouts
RatingsArtiva: Sufficient Cash Runway to 2027 Supports Buy Rating Ahead of Key 2026 RA Efficacy Readouts
28d ago
ARTV
Artiva: De-Risking RA Opportunity With AlloNK and Fast-Track Path Supports Buy Rating
PremiumRatings
Artiva: De-Risking RA Opportunity With AlloNK and Fast-Track Path Supports Buy Rating
28d ago
ARTV
Artiva Biotherapeutics Appoints Thad Huston as Chief Financial Officer
PremiumCompany Announcements
Artiva Biotherapeutics Appoints Thad Huston as Chief Financial Officer
1M ago
8K
ARTV
Artiva Biotherapeutics appoints Huston as Chief Financial Officer
PremiumThe Fly
Artiva Biotherapeutics appoints Huston as Chief Financial Officer
1M ago
ARTV
Artiva Biotherapeutics Adds Veteran Executive Elaine Sorg to Board
PremiumCompany Announcements
Artiva Biotherapeutics Adds Veteran Executive Elaine Sorg to Board
2M ago
8K
ARTV
Artiva Biotherapeutics appoints Sorg to board of directors
PremiumThe FlyArtiva Biotherapeutics appoints Sorg to board of directors
2M ago
ARTV
Artiva (ARTV): Off‑the‑Shelf AlloNK Platform Positions Lead RA Program for Pivotal De‑Risking and Attractive Risk‑Reward
Premium
Ratings
Artiva (ARTV): Off‑the‑Shelf AlloNK Platform Positions Lead RA Program for Pivotal De‑Risking and Attractive Risk‑Reward
2M ago
ARTV
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
4M ago
ARTV
BCRX
Artiva Biotherapeutics Executes RSU Exchange for Employees
PremiumCompany Announcements
Artiva Biotherapeutics Executes RSU Exchange for Employees
4M ago
8K
ARTV
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development
PremiumCompany Announcements
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development
5M ago
ARTV
Promising Developments in Artiva Biotherapeutics’ AlloNK Therapy for Autoimmune Diseases
PremiumRatings
Promising Developments in Artiva Biotherapeutics’ AlloNK Therapy for Autoimmune Diseases
5M ago
ARTV
Buy Rating for Artiva Biotherapeutics, Inc. Based on Promising Clinical Results and Competitive Edge
PremiumRatings
Buy Rating for Artiva Biotherapeutics, Inc. Based on Promising Clinical Results and Competitive Edge
5M ago
ARTV
Buy Rating for Artiva Biotherapeutics Based on Promising AlloNK Combination Therapy Results
PremiumRatingsBuy Rating for Artiva Biotherapeutics Based on Promising AlloNK Combination Therapy Results
5M ago
ARTV
Artiva Biotherapeutics Reports Positive AlloNK Trial Results
Premium
Company Announcements
Artiva Biotherapeutics Reports Positive AlloNK Trial Results
5M ago
8K
ARTV
Artiva Biotherapeutics announces safety, translational data from AlloNK
Premium
The Fly
Artiva Biotherapeutics announces safety, translational data from AlloNK
5M ago
ARTV
Artiva Biotherapeutics reports Q3 EPS (88c) vs (92c) last year
PremiumThe Fly
Artiva Biotherapeutics reports Q3 EPS (88c) vs (92c) last year
5M ago
ARTV
Artiva Biotherapeutics Advances with Promising NK Cell Therapy Study
PremiumCompany Announcements
Artiva Biotherapeutics Advances with Promising NK Cell Therapy Study
5M ago
ARTV
Artiva Biotherapeutics Advances Lupus Treatment with Innovative NK-Cell Therapy
PremiumCompany Announcements
Artiva Biotherapeutics Advances Lupus Treatment with Innovative NK-Cell Therapy
5M ago
ARTV
Artiva Biotherapeutics Advances in Cancer Therapy with GCC2005 Study Update
PremiumCompany Announcements
Artiva Biotherapeutics Advances in Cancer Therapy with GCC2005 Study Update
5M ago
ARTV
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Friday’s Biggest Stock Market Stories!
6M ago
BP
MU
Why Is Artiva Biotherapeutics Stock (ARTV) Up 105% Today?
Premium
Market News
Why Is Artiva Biotherapeutics Stock (ARTV) Up 105% Today?
6M ago
ARTV
Morning Movers: Regional banks in focus after reporting Q3 results
Premium
The Fly
Morning Movers: Regional banks in focus after reporting Q3 results
6M ago
MU
AXP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >